To the Editor: Transient left ventricular apical ballooning (AB) is characterized as a reversible apical balloon-like left ventricular wall motion abnormality. In contrast to patients with acute myocardial infarction (MI), patients with AB do not have obstructive coronary heart disease (CHD) and experience almost complete recovery of cardiac function. Excess sympathetic activity and cardiac sympathovagal disbalance seems to play a major part in the origin of this syndrome. Experimental data suggest high catecholamine plasma concentrations and activation of cardiac adrenoreceptors (1); however, cardiac sympathovagal activity has not yet been studied in patients with AB. The aim of the present study was to investigate differences in reflex and tonic sympathovagal activity in patients with AB compared with patients with successfully reperfused acute anterior MI.
Continuous and categorical variables were compared with the Student t test and the Mann-Whitney U test. Data are presented as mean Ϯ SD. A two-tailed significance level of 0.05 was used for the analyses.
Among the 11 patients with AB, 9 fulfilled the clinical and technical inclusion criteria. There were no significant differences regarding demographic variables, left ventricular ejection fraction, medication, and TIMI risk score (4) between groups ( Table 1) . Peak cardiac enzyme release was significantly higher in MI patients. Measurements of HRT and HRV are depicted in Table 2 . Standard deviation of NN intervals (SDNN) and high-frequency component were significantly higher in the AB group. Lowfrequency/high-frequency ratio revealed a shift towards sympathetic predominance in MI patients compared with AB patients. The AB patients also exhibited significantly higher values for turbulence slope. Mean RR-intervals tended to be higher in AB patients.
The present study is the first to investigate cardiac sympathovagal activity in patients with AB. The principal finding was that, in contrast to matched patients with reperfused anterior MI, tonic and reflex autonomic activity is preserved in the subacute phase of AB. This observation might suggest a rapid attenuation of cardiac autonomic impairment in the subacute phase of AB, resulting in electrical stability and reduced oxygen demand of the affected myocardium.
Although AB clinically mimics ST-segment elevation MI, invasive and laboratory findings suggest a nonischemic cause of the disease. Recent data suggest that excess sympathetic activity play a major role in the origin of the syndrome. In the majority of patients, history of emotional or physiological stress was observed immediately before the onset of the acute event. Interestingly, there are contrary results, thus far, regarding circulating catecholamine concentrations in AB (5). Owa et al. (6) suggested apical disturbance of cardiac sympathetic innervation and perfusion/innervation discrepancy as the origin of AB. The hypothesis of excess sympathetic activation in AB is 
supported by experimental data, showing that stress induces reversible left ventricular apical hypokinesia (1) . Furthermore, in the apical region of the heart, a higher adrenergic receptor density and myocardial responsiveness to adrenergic stimulation has been described (7). The findings of the present study support the hypothesis that, not increased sympathetic autonomic activity directed to the heart, but rather, increased myocardial adrenergic responsiveness might be the underlying pathophysiologic mechanism. Indeed, low-frequency component, associated with cardiac sympathetic modulation, was not significantly elevated in AB. Furthermore, sympathovagal balance and baroreflex function were even more preserved in patients with AB. Therefore, the absence of the deleterious effects on reflex afferent and efferent autonomic function and tonic autonomic modulation in transient left ventricular AB suggest a preserved cardiac autonomic control. The blunted turbulence slope in patients with MI either suggests a faster recovery of baroreflex control in AB patients or a significant impact of coronary artery disease (CAD) on autonomic reflexes beyond acute myocardial ischemia.
Complete reperfusion of the infarct-related artery is associated with a significant restoration of baroreflex sensitivity, whereas incomplete reperfusion causes persistent impairment of baroreflex response, reflecting a more severe microvascular dysfunction (8) . Despite angiographic evidence of complete epicardial perfusion, patients with MI, in contrast to patients with AB, might have a mismatch between vascular patency and myocardial perfusion. Accordingly, microvascular dysfunction has been previously ruled out also by measurements of coronary flow reserve, contrast echocardiography, and positron emission computer tomography in patients with AB (9). Serum cardiac troponin T, which is related to the amount of microvascular damage and dysfunction, was also not significantly elevated in AB patients. Therefore, significantly higher turbulence slope, surrogate marker for baroreflex sensitivity, might reflect a significant rapid improvement of the transient perfusion/innervation mismatch in AB patients.
The present study is the first to demonstrate significant differences of cardiac autonomic modulation in patients with acute ST-segment elevation MI with and without obstructive CAD. In contrast to AB patients, there is a delayed recovery of tonic and reflex autonomic nervous modulation in MI patients. These differences in autonomic modulation represent a previously unrecognized phenomenon that needs further investigation for understanding the underlying pathophysiological mechanisms in AB. Improved cardiac autonomic function might explain, in part, the rapid recovery of left ventricular function and favorable prognosis in patients with AB. HF ϭ high-frequency component; HRT ϭ heart rate turbulence; HRV ϭ heart rate variability; LF ϭ low-frequency component; rMSSD ϭ root mean square of succesive differences; SDANN ϭ standard deviation of the average NN interval; SDNN ϭ standard deviation of NN intervals; TP ϭ total power; VLF ϭ very-low-frequency component.
Bridging the Resource Gap in Heart Failure Expertise and Management: The Underacknowledged Role of Nurse Specialists
Recent studies in the Journal have raised concerns regarding the limited availability of heart failure (HF) specialists. Because HF care now incorporates increasingly complicated strategies and technologies, and because the number of HF patients is burgeoning, capable and specialized providers are in greater demand. The backbone of management must not be forgotten, however, and, as Konstam (1) suggests, "highly specialized clinicians" will clearly be needed to master the evaluation of the HF patient and the timing of HF interventions. The foundation of HF care rests upon the cognitive aspects: identifying and diagnosing the problem, using evidence-based medications, maintaining appropriate intravascular volume status, educating patients about the disease process, and considering device-related and end-of-life issues. Those termed "plumbers" and "electricians" by Naccarelli (2) should not replace, but augment, those who provide the cognitive aspects of HF care. However, economic remuneration and exciting advances in procedural therapies have led many cardiologists away from the core of HF management, resulting in a shortage of HF providers. Less attention has been paid to the comprehensive strategies provided by specially trained nurses who have shown improved HF outcomes in the past and should not be overlooked as other solutions are posed. When studied in the context of multidisciplinary teams, often led by cardiologists, nurse specialists have been shown to contribute significantly to improving outcomes. The review by McAlister et al. (3) of 29 trials has identified that one of the three "crucial" elements in a successful program is the use of specially trained HF nurses. What role do nurse specialists have in HF management? They are able to monitor patients' intravascular volume status, titrate HF medications, triage and often avert admissions with appropriate telemanagement, and educate patients and families. Additionally, nurse specialists assist with complex levels of care when faced with end-stage strategies of transplant, end-of-life issues, or mechanical support.
Finally, the growing global burden of HF necessitates the investigation into alternative methods of providing coordinated, integrated, and focused care for patients. Though a clear need exists for subspecialized care of HF patients so that all appropriate options can be provided, the role that nurse specialists play in managing patients across the spectrum should be fully acknowledged. Nurse specialists should be part of the solution to the growing HF provider shortage, as multidisciplinary HF team
